CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial Endocardium Minimally Contributes to Coronary Endothelium in the Embryonic Ventricular Free Walls Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote Atherosclerosis
|<<... 130 131 132 133 134 135 136 ...>>|

Original Research2017 Nov 1;38(41):3056-3065.

JOURNAL：Eur Heart J. Article Link

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014

Szummer K, Wallentin L, Lindhagen L et al. Keywords: Registry, Myocardial infarction, Time-trends, Outcomes

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top